APA (7th ed.) Citation

Buder-Bakhaya, K., & Hassel, J. C. (2018). Biomarkers for clinical benefit of immune checkpoint inhibitor treatment: A review from the melanoma perspective and beyond. Frontiers in immunology, 9, . https://doi.org/10.3389/fimmu.2018.01474

Chicago Style (17th ed.) Citation

Buder-Bakhaya, Kristina, and Jessica C. Hassel. "Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment: A Review from the Melanoma Perspective and Beyond." Frontiers in Immunology 9 (2018). https://doi.org/10.3389/fimmu.2018.01474.

MLA (9th ed.) Citation

Buder-Bakhaya, Kristina, and Jessica C. Hassel. "Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment: A Review from the Melanoma Perspective and Beyond." Frontiers in Immunology, vol. 9, 2018, https://doi.org/10.3389/fimmu.2018.01474.